Zai Lab (ZLAB) Cash & Current Investments (2016 - 2026)
Zai Lab (ZLAB) posted Cash & Current Investments of $751.3 million for Q1 2026, down 3.62% sequentially from $779.6 million in Q4 2025, and down 12.36% YoY from $857.3 million in Q1 2025.
Zai Lab (ZLAB) Cash & Current Investments (2016 - 2026) Analysis & Trends
Zai Lab has reported Cash & Current Investments for 11 years, with the latest figure at $751.3 million in Q1 2026.
- Quarterly Cash & Current Investments fell 12.36% year-over-year to $751.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $751.3 million (down 12.36% YoY) and the FY2025 annual result came in at $779.6 million, changed 0.01% from the prior year.
- Cash & Current Investments slipped to $751.3 million in Q1 2026 per ZLAB's latest filing, from $779.6 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $1.3 billion in Q1 2022 and troughed at $716.1 million in Q3 2024.
- A 5-year average of $890.7 million and a median of $820.4 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments rose 29.49% in 2022, then slumped 30.37% in 2023.
- Over 5 years, Cash & Current Investments stood at $1.0 billion in 2022, then dropped by 20.03% to $806.5 million in 2023, then declined by 3.32% to $779.7 million in 2024, then retreated by 0.01% to $779.6 million in 2025, then declined by 3.62% to $751.3 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $751.3 million, $779.6 million, and $817.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 836.99 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.16 Bn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 707.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 707.52 Mn |
| Mar 31, 2026 | 751.32 Mn |
| Dec 31, 2025 | 779.57 Mn |
| Sep 30, 2025 | 817.16 Mn |
| Jun 30, 2025 | 832.27 Mn |
| Mar 31, 2025 | 857.26 Mn |
| Dec 31, 2024 | 779.67 Mn |
| Sep 30, 2024 | 716.09 Mn |
| Jun 30, 2024 | 730.05 Mn |
| Mar 31, 2024 | 750.78 Mn |
| Dec 31, 2023 | 806.45 Mn |
| Sep 30, 2023 | 820.41 Mn |
| Jun 30, 2023 | 874.66 Mn |
| Mar 31, 2023 | 930.39 Mn |
| Dec 31, 2022 | 1.01 Bn |
| Sep 30, 2022 | 1.12 Bn |
| Jun 30, 2022 | 1.26 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.41 Bn |
| Sep 30, 2021 | 1.57 Bn |